BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18598736)

  • 21. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L; Zhao C; Yan M; Zhang LY; Xia YZ
    Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing neuroprotective P-glycoprotein activity at the blood-brain barrier in killifish (Fundulus heteroclitus) using behavioural profiles.
    Bard SM; Gadbois S
    Mar Environ Res; 2007 Dec; 64(5):679-82. PubMed ID: 17889328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs.
    Linnet K; Ejsing TB
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):157-69. PubMed ID: 17683917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier.
    Zhang DM; He ZW; Liu XD; Li Y; Xie L; Wang GJ; Liu L
    J Pharm Pharmacol; 2007 Dec; 59(12):1733-8. PubMed ID: 18053337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinidine as an ABCB1 probe for testing drug interactions at the blood-brain barrier: an in vitro in vivo correlation study.
    Sziráki I; Erdo F; Beéry E; Molnár PM; Fazakas C; Wilhelm I; Makai I; Kis E; Herédi-Szabó K; Abonyi T; Krizbai I; Tóth GK; Krajcsi P
    J Biomol Screen; 2011 Sep; 16(8):886-94. PubMed ID: 21832259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unconjugated bilirubin efflux by bovine brain microvascular endothelial cells in vitro.
    Sequeira D; Watchko JF; Daood MJ; O'Day TL; Mahmood B
    Pediatr Crit Care Med; 2007 Nov; 8(6):570-5. PubMed ID: 17906594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro cytotoxicity and P-glycoprotein modulating effects of geranylated furocoumarins from Tetradium daniellii.
    Adams M; Mahringer A; Bauer R; Fricker G; Efferth T
    Planta Med; 2007 Nov; 73(14):1475-8. PubMed ID: 17992628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-β1 regulation of multidrug resistance P-glycoprotein in the developing male blood-brain barrier.
    Baello S; Iqbal M; Bloise E; Javam M; Gibb W; Matthews SG
    Endocrinology; 2014 Feb; 155(2):475-84. PubMed ID: 24265456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of Eu3+ chelates in cells expressing or not P-glycoprotein: implications for blood-brain barrier crossing.
    Darghal N; Garnier-Suillerot A; Bouchemal N; Gras G; Geraldes CF; Salerno M
    J Inorg Biochem; 2010 Jan; 104(1):47-54. PubMed ID: 19875174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.
    de Vries EF; Doorduin J; Vellinga NA; van Waarde A; Dierckx RA; Klein HC
    Nucl Med Biol; 2008 May; 35(4):459-66. PubMed ID: 18482683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease.
    Schapira AH
    Mov Disord; 2008; 23 Suppl 3():S515-20. PubMed ID: 18781678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia.
    Bebawy M; Chetty M
    Bioessays; 2008 Feb; 30(2):183-8. PubMed ID: 18200566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An active transport system in the blood-brain barrier may reduce levodopa availability.
    Hawkins RA; Mokashi A; Simpson IA
    Exp Neurol; 2005 Sep; 195(1):267-71. PubMed ID: 15925365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier.
    Tilloy S; Monnaert V; Fenart L; Bricout H; Cecchelli R; Monflier E
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2154-7. PubMed ID: 16464592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
    Ueno M; Nakagawa T; Huang CL; Ueki M; Kusaka T; Hosomi N; Kanenishi K; Onodera M; Wu B; Sakamoto H
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):147-55. PubMed ID: 19284476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1.
    Caminada D; Zaja R; Smital T; Fent K
    Aquat Toxicol; 2008 Nov; 90(3):214-22. PubMed ID: 18950875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells.
    Liou HH; Hsu HJ; Tsai YF; Shih CY; Chang YC; Lin CJ
    Life Sci; 2007 Aug; 81(8):664-72. PubMed ID: 17689566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P-glycoprotein has negligible effects on estradiol and testosterone in mice.
    Ebinger M; Behl C; Rosenhagen M; Uhr M
    Neurosci Lett; 2007 Oct; 427(1):6-9. PubMed ID: 17923326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of P-glycoprotein at the nuclear envelope of rat brain cells.
    Babakhanian K; Bendayan M; Bendayan R
    Biochem Biophys Res Commun; 2007 Sep; 361(2):301-6. PubMed ID: 17651695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa.
    Adams M; Mahringer A; Kunert O; Fricker G; Efferth T; Bauer R
    Planta Med; 2007 Dec; 73(15):1554-7. PubMed ID: 18058680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.